UNSPSC 41181862: Planetree allergenic extracts

In this classification, this entry connotes an extract made of Planetree used in an Immunological Allergenic test.

UNSPSC 41181862 Planetree allergenic extracts is a Commodity code that shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's name suggests botanical allergen products for medical testing or immunotherapy, yet the recent solicitations under this code overwhelmingly reflect clinical laboratory testing services — specifically HIV, Syphilis, and Hepatitis screening — drug testing, forensic analysis, and pool maintenance. State and local governments posting under this code are acquiring diagnostic testing kits, reagent supplies, laboratory instrumentation, specimen collection services, and expert witness testimony for criminal justice and public health purposes. Issuing bodies include state health departments (Illinois Department of Public Health), state criminal justice agencies (Texas Department of Criminal Justice), county community supervision departments (Collin County), municipal public health programs (City of Austin), and higher-education institutions (University of Houston).

Activity concentrates in Texas and Illinois, with recent opportunities spanning February through July 2026. Representative solicitations include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services with a response deadline of July 23, 2026 and estimated value of $600,000 over two years; the City of Austin's IFB 9100AAM1023 for rapid HIV test kits due July 17, 2026; the Illinois Department of Public Health's emergency procurement (reference 26482DPHOFCDIB52638) for Abbott HIV and Syphilis reagents due August 18, 2026 totaling $38,079.50; and the Texas Department of Criminal Justice's RFP 696-IG-26-P034 for forensic analysis and expert witness testimony services with a May 13, 2026 deadline. The code's current use appears to reflect a data-classification mismatch rather than genuine demand for allergenic extracts, limiting its utility for vendors in botanical or immunotherapy sectors.